Sarah Ondrejka, DO
Hematopathology
Highlights
Age Groups Seen
- Adult
Languages
- English
Gender
FemaleAbout Sarah Ondrejka
Biography
Sarah Ondrejka, DO, is a Staff Physician in the Pathology and Laboratory Medicine Institute at Cleveland Clinic. She graduated from the Ohio University Heritage College of Osteopathic Medicine in Athens, Ohio. She completed residency in Anatomic and Clinical Pathology at Cleveland Clinic (Cleveland, Ohio) and a two-year fellowship in Hematopathology at Cleveland Clinic, and has been in practice in the department of Laboratory Medicine since 2014. Dr. Ondrejka serves as the Medical Director of Flow Cytometry.
Dr. Ondrejka specializes in diagnostic interpretation of bone marrow aspirates and biopsies, peripheral blood smears, body fluids, lymph node biopsies, flow cytometry, hemostasis and thrombosis tests, and other laboratory hematology tests. Her interests include Hodgkin and non-Hodgkin lymphomas, diseases of the bone marrow, and analysis of hemoglobinopathies and thalassemias. She is passionate about applying up-to-date practices in hematopathology to achieve a helpful and concise diagnosis that may impact patient experience and outcome.
She is board certified in Anatomic and Clinical Pathology and Hematology. She is a fellow of the College of American Pathologists and the American Society for Clinical Pathology, and is a member of the United States and Canadian Academy of Pathology, the Society for Hematology, the American Society of Hematology, and the International Society for Laboratory Hematology.
Education & Board Certifications
Education
- Fellowship: Cleveland Clinic, 2014
- Fellowship: Cleveland Clinic, 2013
- Residency: Cleveland Clinic, 2012
- Medical Education: Ohio University College of Osteopathic Medicine, 2008
- Undergraduate: Miami University, 2004
Board Certifications
- Hematopathology: American Board of Pathology, 2025
- Anatomic & Clinical Pathology: American Board of Pathology, 2012
Research & Publications
See publications for this provider. (Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Industry Relationships
Cleveland Clinic physicians and scientists collaborate with industry to advance medical breakthroughs. These partnerships help commercialize discoveries for public benefit while maintaining scientific integrity. To ensure transparency and minimize potential bias, Cleveland Clinic reviews these relationships and publicly discloses when physicians/scientists receive significant compensation for consulting, serve in fiduciary roles, receive royalties, or hold equity interests related to their work. We manage potential conflicts through approval processes, annual reporting, and targeted management plans.
As of 2025-07-15, Dr. Ondrejka has reported no financial relationship with industry that is applicable to this listing.
In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.
* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.